Janney Montgomery Scott’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,000
Closed -$2K 2764
2023
Q1
$2K Hold
10,000
﹤0.01% 2447
2022
Q4
$6K Hold
10,000
﹤0.01% 2549
2022
Q3
$12K Hold
10,000
﹤0.01% 2478
2022
Q2
$6K Hold
10,000
﹤0.01% 2308
2022
Q1
$11K Hold
10,000
﹤0.01% 2225
2021
Q4
$22K Hold
10,000
﹤0.01% 2358
2021
Q3
$34K Hold
10,000
﹤0.01% 2281
2021
Q2
$30K Hold
10,000
﹤0.01% 2239
2021
Q1
$32K Buy
+10,000
New +$33.4K ﹤0.01% 2156

Other funds holding INFI

Janney Montgomery Scott's INFI Position: Q2 2023 in Review

Janney Montgomery Scott sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2023, closing a stake of 10,000 shares — an estimated $2K sold.

Janney Montgomery Scott first reported a position in INFI in Q1 2021 and held it in 9 quarters. The position peaked at $34K in Q3 2021. 45 funds tracked by Wall St. Rank hold INFI as of Q2 2023.

  • Janney Montgomery Scott reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Janney Montgomery Scott sold 10,000 Infinity Pharmaceuticals, Inc. shares in Q2 2023, an estimated $2K.
  • Janney Montgomery Scott first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2021 and held it in 9 quarters.
  • Janney Montgomery Scott's Infinity Pharmaceuticals, Inc. position peaked at $34K in Q3 2021.
  • 45 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2023.

Based on Janney Montgomery Scott's 13F filing for Q2 2023, filed 26 Jul 2023.